Abstract:One of the most common life-threatening infections in immunosuppressive patients, like AIDs patients, is cryptococcal meningitis or meningoencephalitis. Current therapeutic options are mostly ineffective and mortality rates remain high. Hydrophobic antifungal drug Amphotericin B (AmB), has become a golden standard in severe systemic fungal infection therapy. However, most AmB commercial formulations, including deoxycholate AmB and lipid formulations of AmB, show poor penetration into the CNS and difficulty to reach the therapeutic levels. To improve the CNS permeability of AmB, we have successfully developed an effective brain-targeting polymeric micellar system with angiopep-2 modified, named Angiopep-PEG-PE/AmB polymeric micelles. An immunosuppressive murine model with Cryptococcus neoformans meningoencephalitis (CNME) was established to evaluate the CNS penetration efficiency and antifungal treatment efficacy of the AmB-incorporated brain-vectored polymeric micellar formulation, compared with the AmB commercial formulations. After three consecutive days of i.v. administration, the results showed that the group treated with Angiopep-PEG-PE/AmB achieved the greatest treatment efficacy, which reached the highest AmB level in brain, reduced the brain fungal burden significantly, decreased histopathological severity and prolonged the median survival time. The increased treatment efficacy could be attributed to the brain-targeting delivery system promoted AmB crossing the BBB and penetrating into the brain to reach the therapeutic concentration. The underlying mechanism was also explored in this work. Therefore, the brain-targeting delivery system could have potential and promising implications for treatment of intracerebral fungal infection.

Discovery of Novel Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis.

Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents.

Discovery of New Tricyclic Oxime Sampangine Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcosis and Candidiasis

Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis.

Discovery of Simplified Sampangine Derivatives As Novel Fungal Biofilm Inhibitors.

Discovery of Novel Sertraline Derivatives as Potent Anti- Cryptococcus Agents

Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Discovery of New Fungal Jumonji H3K27 Demethylase Inhibitors for the Treatment of Cryptococcus Neoformans and Candida Auris Infections

Novel antifungal agents against cryptococcal infections

Discovery of Novel Sertraline Derivatives as Potent Anti-CryptococcusAgents br

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

A Brain-Vectored Angiopep-2 Based Polymeric Micelles for the Treatment of Intracranial Fungal Infection

Drug Repurposing of Haloperidol: Discovery of New Benzocyclane Derivatives As Potent Antifungal Agents Against Cryptococcosis and Candidiasis.

Design, synthesis and <i>in vitro</i> biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Molecular Docking, Design, Synthesis and Antifungal Activity Study of Novel Triazole Derivatives

Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration.

Scaffold Hopping of Sampangine: Discovery of Potent Antifungal Lead Compound Against Aspergillus Fumigatus and Cryptococcus Neoformans.

Discovery of Biphenyl Imidazole Derivatives As Potent Antifungal Agents: Design, Synthesis, and Structure-Activity Relationship Studies.

Discovery of Novel Isothiazole, 1,2,3-Thiadiazole and Thiazole Based Cinnamamides as Fungicidal Candiate.